Black Diamond Therapeutics, Inc.
US ˙ NasdaqGS ˙ US09203E1055

Introduzione

Questa pagina fornisce un'analisi completa dello storico delle operazioni di insider trading note di Bradley J PhD Bolzon. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4. Nonostante queste restrizioni, la ricerca accademica suggerisce che gli insider, in generale, tendono a sovraperformare il mercato nelle proprie società.

Redditività media delle transazioni

La redditività media delle transazioni è il rendimento medio di tutti gli acquisti effettuati sul mercato aperto dagli insider negli ultimi tre anni. Pe calcolarla, esaminiamo tutti gli acquisti non pianificati effettuati dall'insider sul mercato aperto, escludendo tutte le operazioni che sono state parte di un piano di trading 10b5-1. Calcoliamo quindi la performance media di queste operazioni nell'arco di 3, 6 e 12 mesi e facciamo la media di ciascuna di queste durate per generare un indicatore di performance finale per ogni operazione. Infine, facciamo la media di tutti gli indicatori di performance per calcolare un indicatore di performance per l'insider. Questo elenco comprende solo gli insider che hanno effettuato almeno tre operazioni negli ultimi due anni.

Se la redditività delle operazioni di questo insider è "N/D", l'insider non ha effettuato acquisti sul mercato aperto negli ultimi tre anni, oppure le operazioni effettuate sono troppo recenti per poter calcolare un indicatore di performance affidabile.

Frequenza di aggiornamento: giornaliera

Vedi l'elenco degli insider trader più redditizi

Società con posizioni di insider dichiarate

I depositi SEC indicano che Bradley J PhD Bolzon ha dichiarato partecipazioni o transazioni nelle seguenti società:

Titolo Ruolo Ultime partecipazioni dichiarate
US:CRSP / CRISPR Therapeutics AG Director 148.831
US:GLUE / Monte Rosa Therapeutics, Inc. Director, 10% Owner 0
US:BDTX / Black Diamond Therapeutics, Inc. Director, 10% Owner 15.000
US:FLXN / Horizon Funds - Horizon Flexible Income ETF 10% Owner 20.739
US:PZRX / PhaseRx, Inc. 10% Owner 1.931.094
US:INGN / Inogen, Inc. 10% Owner 55.345
US:EYES / Corgi ETF Trust I - Corgi Data & Surveillance ETF 10% Owner 4.370.964
Come interpretare i grafici

I grafici seguenti mostrano l'andamento dei titoli dopo ogni operazione di mercato aperto non pianificata effettuata da Bradley J PhD Bolzon. Per operazioni non pianificate si intendono operazioni non effettuate nell'ambito di un piano di trading 10b5-1. La performance dei titoli è rappresentata come variazione percentuale cumulativa del prezzo delle azioni. Ad esempio, se un'operazione di insider è stata effettuata il 1° gennaio 2019, il grafico mostrerà la variazione percentuale giornaliera del titolo fino ad oggi. Se il prezzo dell'azione passasse da 10 a 15 dollari durante questo periodo, la variazione percentuale cumulativa del prezzo dell'azione sarebbe del 50%. Una variazione di prezzo da 10 a 20 dollari sarebbe del 100%, mentre una variazione di prezzo da 10 a 5 dollari sarebbe del -50%.

In definitiva, cerchiamo di determinare la correlazione tra le operazioni dell'insider e i rendimenti in eccesso (positivi o negativi) del prezzo dell'azione, al fine di capire se l'insider sta programmando le proprie operazioni per trarre profitto da informazioni privilegiate. Immaginiamo che un insider stia facendo questo. In questa situazione, ci aspetteremmo (a) rendimenti positivi dopo gli acquisti, oppure (b) rendimenti negativi dopo le vendite. Nel caso (a), il grafico ACQUISTO mostrerebbe una serie di curve ascendenti, indicando rendimenti positivi dopo ogni operazione di acquisto. Nel caso (b), il grafico VENDITA mostrerebbe una serie di curve inclinate verso il basso, indicando rendimenti negativi dopo ogni operazione di vendita.

Tuttavia, questo non è sufficiente per trarre conclusioni. Se, ad esempio, il prezzo delle azioni della società è aumentato in maniera non ciclica per molti anni, allora ci aspetteremmo che tutti i grafici post-acquisto abbiano una pendenza rivolta verso l'alto. Allo stesso modo, ribassi non ciclici per molti anni darebbero luogo a grafici post-negoziazione rivolti verso il basso. Nessuno di questi grafici suggerisce un'attività di insider trading.

L'indicatore più forte sarebbe una situazione in cui il prezzo delle azioni fosse estremamente ciclico e vi fossero segnali positivi nel grafico ACQUISTO e curve negative nel grafico VENDITA. Questa situazione suggerirebbe che l'insider sta programmando le operazioni di trading per trarne un vantaggio finanziario.

Acquisti di insider BDTX / Black Diamond Therapeutics, Inc. - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in BDTX / Black Diamond Therapeutics, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
2020-02-03 BDTX Bolzon Bradley J PhD 79.013 19,0000 79.013 19,0000 1.501.247 140 44.8 2.038.535 135,79
2020-02-03 BDTX Bolzon Bradley J PhD 23.560 19,0000 23.560 19,0000 447.640
2020-02-03 BDTX Bolzon Bradley J PhD 396.082 19,0000 396.082 19,0000 7.525.558
2020-02-03 BDTX Bolzon Bradley J PhD 396.081 19,0000 396.081 19,0000 7.525.539

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

BDTX / Black Diamond Therapeutics, Inc. Insider Trades
Vendite di insider BDTX / Black Diamond Therapeutics, Inc. - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in BDTX / Black Diamond Therapeutics, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

BDTX / Black Diamond Therapeutics, Inc. Insider Trades
Acquisti di insider EYES / Corgi ETF Trust I - Corgi Data & Surveillance ETF - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in BDTX / Black Diamond Therapeutics, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

EYES / Corgi ETF Trust I - Corgi Data & Surveillance ETF Insider Trades
Vendite di insider EYES / Corgi ETF Trust I - Corgi Data & Surveillance ETF - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in BDTX / Black Diamond Therapeutics, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

EYES / Corgi ETF Trust I - Corgi Data & Surveillance ETF Insider Trades
Acquisti di insider FLXN / Horizon Funds - Horizon Flexible Income ETF - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in BDTX / Black Diamond Therapeutics, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

FLXN / Horizon Funds - Horizon Flexible Income ETF Insider Trades
Vendite di insider FLXN / Horizon Funds - Horizon Flexible Income ETF - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in BDTX / Black Diamond Therapeutics, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

FLXN / Horizon Funds - Horizon Flexible Income ETF Insider Trades
Acquisti di insider GLUE / Monte Rosa Therapeutics, Inc. - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in BDTX / Black Diamond Therapeutics, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
2021-06-28 GLUE Bolzon Bradley J PhD 157.895 19,0000 157.895 19,0000 3.000.005 67 42.21 3.664.743 122,16

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

GLUE / Monte Rosa Therapeutics, Inc. Insider Trades
Vendite di insider GLUE / Monte Rosa Therapeutics, Inc. - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in BDTX / Black Diamond Therapeutics, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

GLUE / Monte Rosa Therapeutics, Inc. Insider Trades
Acquisti di insider INGN / Inogen, Inc. - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in BDTX / Black Diamond Therapeutics, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

INGN / Inogen, Inc. Insider Trades
Vendite di insider INGN / Inogen, Inc. - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in BDTX / Black Diamond Therapeutics, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
2015-01-05 INGN Versant Ventures II LLC 7.946 30,9790 7.946 30,9790 246.159 35 29.7800 -9.527 -3,87
2014-12-23 INGN Versant Ventures II LLC 9.785 29,7403 9.785 29,7403 291.009
2014-11-19 INGN Versant Ventures II LLC 3.500 24,2162 3.500 24,2162 84.757
2014-11-18 INGN Versant Ventures II LLC 3.895 24,9177 3.895 24,9177 97.054
2014-11-18 INGN Versant Ventures II LLC 7.953 24,7904 7.953 24,7904 197.158
2014-11-17 INGN Versant Ventures II LLC 7.534 24,8636 7.534 24,8636 187.322
2014-11-13 INGN Versant Ventures II LLC 5.505 25,1844 5.505 25,1844 138.640
2014-11-10 INGN Versant Ventures II LLC 3.041 24,5682 3.041 24,5682 74.712
2014-11-10 INGN Versant Ventures II LLC 5.596 24,4781 5.596 24,4781 136.979
2014-11-07 INGN Versant Ventures II LLC 3.150 23,9499 3.150 23,9499 75.442
2014-11-06 INGN Versant Ventures II LLC 4.238 24,5617 4.238 24,5617 104.092

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

INGN / Inogen, Inc. Insider Trades
Storico delle operazioni degli insider

Questa tabella mostra l'elenco completo delle operazioni effettuate da Bradley J PhD Bolzon come comunicato alla Securities Exchange Commission (SEC).

Data di deposito Data della transazione Modulo Ticker Titolo Codice 10b5-1 Azioni Azioni rimanenti Variazione
percentuale
Prezzo
dell'azione
Valore
della transazione
Valore
rimanente
2021-07-21 2021-07-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -700 148.831 -0,47 128,71 -90.094 19.155.398
2021-07-21 2021-07-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.324 149.531 -0,88 127,36 -168.619 19.043.670
2021-07-21 2021-07-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -4.472 150.855 -2,88 126,41 -565.289 19.069.022
2021-07-21 2021-07-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -3.504 155.327 -2,21 125,67 -440.345 19.519.835
2021-06-30 2021-06-28 4 GLUE Monte Rosa Therapeutics, Inc.
Series C convertible preferred stock
C - Conversion -2.699.328 0 -100,00
2021-06-30 2021-06-28 4 GLUE Monte Rosa Therapeutics, Inc.
Series B convertible preferred stock
C - Conversion -4.150.000 0 -100,00
2021-06-30 2021-06-28 4 GLUE Monte Rosa Therapeutics, Inc.
Series B convertible preferred stock
C - Conversion -3.000.000 0 -100,00
2021-06-30 2021-06-28 4 GLUE Monte Rosa Therapeutics, Inc.
Series A convertible preferred stock
C - Conversion -20.004.280 0 -100,00
2021-06-30 2021-06-28 4 GLUE Monte Rosa Therapeutics, Inc.
Common Stock
P - Purchase 157.895 2.097.938 8,14 19,00 3.000.005 39.860.822
2021-06-30 2021-06-28 4 GLUE Monte Rosa Therapeutics, Inc.
Common Stock
C - Conversion 1.940.043 1.940.043
2021-06-30 2021-06-28 4 GLUE Monte Rosa Therapeutics, Inc.
Common Stock
C - Conversion 6.515.869 6.799.115 2.300,43
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -269 158.831 -0,17 156,54 -42.110 24.863.627
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -549 0 -100,00 156,54 -85.941
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -132 159.100 -0,08 155,27 -20.496 24.703.855
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -268 549 -32,80 155,27 -41.613 85.245
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.119 159.232 -0,70 154,57 -172.959 24.611.790
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.281 817 -73,63 154,57 -352.564 126.280
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.218 160.351 -1,36 153,54 -340.549 24.620.116
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -4.519 3.098 -59,33 153,54 -693.842 475.664
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.540 162.569 -0,94 152,38 -234.660 24.771.663
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -3.139 7.617 -29,18 152,38 -478.309 1.160.650
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -3.144 164.109 -1,88 151,49 -476.300 24.861.677
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -6.403 10.756 -37,32 151,49 -970.022 1.629.479
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.578 167.253 -0,93 150,65 -237.726 25.196.715
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -3.216 17.159 -15,78 150,65 -484.491 2.585.008
2021-06-30 2021-06-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.200 0 -100,00 152,42 -182.906
2021-06-30 2021-06-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -6.646 1.200 -84,71 151,24 -1.005.162 181.492
2021-06-30 2021-06-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -12.753 7.846 -61,91 150,49 -1.919.237 1.180.768
2021-06-30 2021-06-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -7.981 20.599 -27,93 149,47 -1.192.915 3.078.920
2021-06-30 2021-06-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -12.176 28.580 -29,88 148,58 -1.809.095 4.246.382
2021-06-30 2021-06-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -4.780 40.756 -10,50 147,43 -704.725 6.008.743
2021-06-30 2021-06-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -600 45.536 -1,30 146,69 -88.016 6.679.826
2021-06-30 2021-06-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.400 46.136 -2,95 145,92 -204.284 6.732.031
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 847 47.536 1,81
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -6.018 0 -100,00
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 6.018 6.018
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other X -27.861 16.434 -62,90
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 18.973 46.689 68,46
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -84.085 0 -100,00
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 2.633 84.085 3,23
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other X -12.189 6.268 -66,04
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 2.378 81.452 3,01
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other X -11.011 5.614 -66,23
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 79.074 79.074
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other X -366.084 215.915 -62,90
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other X -3.650 622 -85,44
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 27.716 27.716
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -158.522 0 -100,00
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 158.522 158.522
2021-06-30 2021-06-28 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other X -615.607 104.874 -85,44
2021-06-25 2021-06-23 4 GLUE Monte Rosa Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 47.132 47.132
2021-06-25 2021-03-11 4 GLUE Monte Rosa Therapeutics, Inc.
Series C convertible preferred stock
A - Award 2.699.328 2.699.328 2,96 7.999.998 7.999.998
2021-06-25 2021-02-24 4 GLUE Monte Rosa Therapeutics, Inc.
Series B convertible preferred stock
A - Award 2.075.000 4.150.000 100,00 2,00 4.150.000 8.300.000
2021-06-25 2021-02-24 4 GLUE Monte Rosa Therapeutics, Inc.
Series B convertible preferred stock
A - Award 1.500.000 3.000.000 100,00 2,00 3.000.000 6.000.000
2021-06-23 3 GLUE Monte Rosa Therapeutics, Inc.
Common Stock
283.246
2021-06-22 2021-06-18 4 BDTX Black Diamond Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 15.000 15.000
2021-06-15 2021-06-11 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -755 20.375 -3,57 129,45 -97.733 2.637.487
2021-06-15 2021-06-11 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.100 21.130 -4,95 128,65 -141.517 2.718.413
2021-06-15 2021-06-11 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -800 22.230 -3,47 127,88 -102.307 2.842.857
2021-06-15 2021-06-11 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.918 23.030 -7,69 126,59 -242.808 2.915.474
2021-06-15 2021-06-11 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.427 24.948 -17,87 125,62 -681.753 3.134.030
2021-06-14 2021-06-10 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 10.000 10.000
2021-03-24 2021-03-22 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -300 30.375 -0,98 134,93 -40.478 4.098.399
2021-03-24 2021-03-22 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.237 30.675 -14,58 134,33 -703.495 4.120.625
2021-03-24 2021-03-22 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -9.334 35.912 -20,63 133,28 -1.244.070 4.786.484
2021-03-24 2021-03-22 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -6.090 45.246 -11,86 132,53 -807.092 5.996.339
2021-03-24 2021-03-22 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.400 51.336 -4,47 131,14 -314.741 6.732.316
2021-03-24 2021-03-22 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -3.413 53.736 -5,97 130,42 -445.112 7.008.066
2021-03-24 2021-03-22 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -3.600 57.149 -5,93 129,36 -465.678 7.392.509
2021-03-03 2021-03-01 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 565 60.749 0,94
2021-03-03 2021-03-01 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -4.012 0 -100,00
2021-03-03 2021-03-01 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 4.012 4.012
2021-03-03 2021-03-01 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other X -18.574 44.295 -29,54
2021-03-03 2021-03-01 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 12.648 60.184 26,61
2021-03-03 2021-03-01 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -56.056 0 -100,00
2021-03-03 2021-03-01 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 1.755 56.056 3,23
2021-03-03 2021-03-01 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other X -8.126 18.457 -30,57
2021-03-03 2021-03-01 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 1.585 54.301 3,01
2021-03-03 2021-03-01 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other X -7.341 16.625 -30,63
2021-03-03 2021-03-01 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 52.716 52.716
2021-03-03 2021-03-01 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other X -244.056 581.999 -29,54
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 847 47.536 1,81
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -6.018 0 -100,00
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 6.018 6.018
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -27.861 62.869 -30,71
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 18.973 46.689 68,46
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -84.085 0 -100,00
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 2.633 84.085 3,23
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -12.189 26.583 -31,44
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 2.378 81.452 3,01
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -11.011 23.966 -31,48
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 79.074 79.074
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -366.084 826.055 -30,71
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -3.650 4.272 -46,07
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 27.716 27.716
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -158.522 0 -100,00
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 158.522 158.522
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -615.607 720.481 -46,08
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -3.463 168.831 -2,01 151,82 -525.752 25.631.889
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -27.932 172.294 -13,95 150,99 -4.217.461 26.014.723
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -38.132 200.226 -16,00 150,10 -5.723.773 30.054.764
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -23.276 238.358 -8,90 149,24 -3.473.785 35.573.311
2021-02-23 2021-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -78.200 261.634 -23,01 147,79 -11.557.069 38.666.523
2020-12-18 2020-12-16 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -931 339.834 -0,27 151,05 -140.625 51.331.042
2020-12-18 2020-12-16 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -969 0 -100,00 151,05 -146.365
2020-12-18 2020-12-16 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -958 340.765 -0,28 150,14 -143.837 51.163.548
2020-12-18 2020-12-16 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -995 969 -50,66 150,14 -149.392 145.489
2020-12-18 2020-12-16 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.009 341.723 -0,58 149,12 -299.586 50.958.486
2020-12-18 2020-12-16 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.091 1.964 -51,57 149,12 -311.815 292.876
2020-12-18 2020-12-16 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.576 343.732 -0,74 148,28 -381.972 50.968.959
2020-12-18 2020-12-16 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.679 4.055 -39,78 148,28 -397.245 601.280
2020-12-18 2020-12-16 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -878 346.308 -0,25 147,00 -129.068 50.907.969
2020-12-18 2020-12-16 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -914 6.734 -11,95 147,00 -134.360 989.911
2020-12-17 2020-12-10 4/A CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -15.900 7.648 -67,52 144,85 -2.303.155 1.107.832
2020-12-17 2020-12-10 4/A CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.223 23.548 -8,63 143,26 -318.462 3.373.437
2020-12-17 2020-12-10 4/A CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.958 25.771 -18,78 142,42 -848.562 3.670.409
2020-12-17 2020-12-10 4/A CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -6.648 31.729 -17,32 141,53 -940.923 4.490.758
2020-12-17 2020-12-10 4/A CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.271 38.377 -5,59 140,62 -319.345 5.396.528
2020-12-16 2020-12-14 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 11 21.851 0,05
2020-12-16 2020-12-14 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -307 0 -100,00
2020-12-16 2020-12-14 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 307 307
2020-12-16 2020-12-14 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -310 0 -100,00
2020-12-16 2020-12-14 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 310 310
2020-12-16 2020-12-14 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -20.784 822.140 -2,47
2020-12-14 2020-12-10 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -15.900 314.186 -4,82 144,85 -2.303.155 45.510.628
2020-12-14 2020-12-10 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.223 330.086 -0,67 143,26 -318.462 47.287.427
2020-12-14 2020-12-10 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.958 332.309 -1,76 142,42 -848.562 47.328.777
2020-12-14 2020-12-10 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -6.648 338.267 -1,93 141,53 -940.923 47.876.552
2020-12-14 2020-12-10 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.271 344.915 -0,65 140,62 -319.345 48.501.533
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -800 347.186 -0,23 163,13 -130.505 56.636.904
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -14.270 347.986 -3,94 162,40 -2.317.497 56.514.110
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -17.627 362.256 -4,64 161,57 -2.848.028 58.530.390
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -9.397 379.883 -2,41 160,50 -1.508.195 60.970.272
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -8.453 389.280 -2,13 159,48 -1.348.077 62.082.024
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -15.260 397.733 -3,69 158,41 -2.417.271 63.003.174
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -8.582 412.993 -2,04 157,54 -1.351.994 65.062.215
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -4.457 421.575 -1,05 156,53 -697.655 65.989.177
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -12.123 426.032 -2,77 155,36 -1.883.422 66.188.076
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -4.300 438.155 -0,97 154,41 -663.943 67.653.498
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -10.098 442.455 -2,23 153,44 -1.549.433 67.890.118
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -600 452.553 -0,13 151,32 -90.790 68.478.827
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -7.067 453.153 -1,54 150,57 -1.064.087 68.231.791
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -9.416 460.220 -2,00 149,41 -1.406.835 68.761.010
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -12.703 469.636 -2,63 148,45 -1.885.729 69.716.290
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -24.077 482.339 -4,75 147,40 -3.548.969 71.097.154
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -4.203 506.416 -0,82 146,57 -616.017 74.223.367
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -2.762 510.619 -0,54 145,43 -401.676 74.258.964
2020-12-09 2020-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -4.809 513.381 -0,93 144,39 -694.384 74.128.417
2020-12-01 2020-11-30 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 15 21.840 0,07
2020-12-01 2020-11-30 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -463 0 -100,00
2020-12-01 2020-11-30 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 463 463
2020-12-01 2020-11-30 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -467 0 -100,00
2020-12-01 2020-11-30 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 467 467
2020-12-01 2020-11-30 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -31.175 842.924 -3,57
2020-12-01 2020-11-30 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -200 874.099 -0,02 34,16 -6.833 29.863.243
2020-12-01 2020-11-30 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -10.193 874.299 -1,15 33,13 -337.680 28.964.302
2020-12-01 2020-11-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 2.256 21.825 11,53
2020-12-01 2020-11-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -6.797 0 -100,00
2020-12-01 2020-11-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 6.797 6.797
2020-12-01 2020-11-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -7.880 0 -100,00
2020-12-01 2020-11-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 7.880 7.880
2020-12-01 2020-11-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -394.000 3.947.941 -9,07
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.164 19.569 6,32
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -3.316 0 -100,00
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 2.488 3.316 300,48
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -46.121 380.942 -10,80
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 828 828
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -154.671 1.277.541 -10,80
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 43 18.405 0,23
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -1.258 0 -100,00
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.258 1.258
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -1.269 0 -100,00
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.269 1.269
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -84.462 884.492 -8,72
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 2.728 18.362 17,45
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -8.223 0 -100,00
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 8.223 8.223
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -9.533 0 -100,00
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 9.533 9.533
2020-11-25 2020-11-23 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -476.659 4.341.941 -9,89
2020-11-23 2020-11-19 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -114.854 4.818.600 -2,33 33,01 -3.791.331 159.061.986
2020-11-23 2020-11-19 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -15.163 968.954 -1,54 33,01 -500.531 31.985.172
2020-11-19 2020-11-18 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -473 4.933.454 -0,01 33,09 -15.653 163.266.740
2020-11-19 2020-11-18 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -63 984.117 -0,01 33,09 -2.085 32.568.171
2020-11-19 2020-11-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -3.705 4.933.927 -0,08 33,05 -122.450 163.065.301
2020-11-19 2020-11-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -489 984.180 -0,05 33,05 -16.161 32.526.952
2020-11-17 2020-11-16 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -177 4.937.632 0,00 33,01 -5.843 163.003.576
2020-11-17 2020-11-16 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -23 984.669 0,00 33,01 -759 32.506.385
2020-11-17 2020-11-13 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -1.502 4.937.809 -0,03 34,53 -51.865 170.506.989
2020-11-17 2020-11-13 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -2.473 4.939.311 -0,05 33,31 -82.388 164.552.652
2020-11-17 2020-11-13 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -198 984.692 -0,02 34,53 -6.837 34.002.301
2020-11-17 2020-11-13 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -327 984.890 -0,03 33,31 -10.894 32.811.512
2020-11-13 2020-11-12 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -353 4.941.784 -0,01 35,15 -12.408 173.697.777
2020-11-13 2020-11-12 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -9.450 4.942.137 -0,19 34,39 -325.012 169.973.929
2020-11-13 2020-11-12 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -3.976 4.951.587 -0,08 33,48 -133.106 165.766.259
2020-11-13 2020-11-12 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -47 985.217 0,00 35,15 -1.652 34.629.195
2020-11-13 2020-11-12 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -1.248 985.264 -0,13 34,39 -42.922 33.885.988
2020-11-13 2020-11-12 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -524 986.512 -0,05 33,48 -17.542 33.025.857
2020-11-13 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.502 15.634 10,63
2020-11-13 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -4.282 0 -100,00
2020-11-13 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 3.211 4.282 299,81
2020-11-13 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -59.534 427.063 -12,23
2020-11-13 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.071 1.071
2020-11-13 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -199.652 1.432.212 -12,23
2020-11-13 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 3.954 14.132 38,85
2020-11-13 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -11.918 0 -100,00
2020-11-13 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 11.918 11.918
2020-11-13 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -13.816 0 -100,00
2020-11-13 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 13.816 13.816
2020-11-13 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -690.814 4.955.563 -12,23
2020-11-12 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -9.027 5.646.377 -0,16 34,94 -315.378 197.268.603
2020-11-12 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -2.119 5.655.404 -0,04 33,86 -71.748 191.489.717
2020-11-12 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -1.191 987.036 -0,12 34,94 -41.610 34.484.274
2020-11-12 2020-11-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -280 988.227 -0,03 33,86 -9.481 33.460.971
2020-11-12 2020-11-10 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -12.433 5.657.523 -0,22 34,14 -424.510 193.169.334
2020-11-12 2020-11-10 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -11.388 5.669.956 -0,20 33,48 -381.245 189.817.653
2020-11-12 2020-11-10 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -1.642 988.507 -0,17 34,14 -56.064 33.751.385
2020-11-12 2020-11-10 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -1.503 990.149 -0,15 33,48 -50.317 33.148.010
2020-11-10 2020-11-09 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -5.565 5.681.344 -0,10 33,06 -183.954 187.800.235
2020-11-10 2020-11-09 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -735 991.652 -0,07 33,06 -24.296 32.779.652
2020-11-10 2020-11-06 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -2.738 5.686.909 -0,05 33,13 -90.706 188.398.765
2020-11-10 2020-11-06 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -362 992.387 -0,04 33,13 -11.993 32.876.293
2020-11-06 2020-11-05 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -7.816 5.689.647 -0,14 33,15 -259.079 188.596.436
2020-11-06 2020-11-05 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -1.032 992.749 -0,10 33,15 -34.208 32.906.949
2020-11-06 2020-11-04 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -2.208 5.697.463 -0,04 33,14 -73.164 188.789.425
2020-11-06 2020-11-04 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -292 993.781 -0,03 33,14 -9.676 32.929.629
2020-11-02 2020-10-29 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 18.477 40.648 83,34
2020-11-02 2020-10-29 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other X -2.433 7.922 -23,50
2020-11-02 2020-10-29 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -105.681 0 -100,00
2020-11-02 2020-10-29 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 105.681 105.681
2020-11-02 2020-10-29 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other X -410.405 1.336.088 -23,50
2020-10-28 2020-10-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -707 5.699.671 -0,01 33,03 -23.354 188.274.382
2020-10-28 2020-10-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -93 994.073 -0,01 33,03 -3.072 32.836.716
2020-10-28 2020-10-26 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -7.158 5.700.378 -0,13 33,30 -238.394 189.848.809
2020-10-28 2020-10-26 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -945 994.166 -0,09 33,30 -31.473 33.110.301
2020-10-20 2020-10-19 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -3.739 5.707.536 -0,07 33,43 -124.998 190.808.065
2020-10-20 2020-10-19 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -494 995.111 -0,05 33,43 -16.515 33.267.456
2020-10-20 2020-10-16 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -7.697 5.711.275 -0,13 33,57 -258.410 191.743.493
2020-10-20 2020-10-16 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -1.016 995.605 -0,10 33,57 -34.110 33.425.248
2020-10-20 2020-10-15 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -2.473 5.718.972 -0,04 33,03 -81.694 188.922.237
2020-10-20 2020-10-15 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -327 996.621 -0,03 33,03 -10.802 32.922.677
2020-10-15 2020-10-14 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -4.859 5.721.445 -0,08 33,09 -160.787 189.326.048
2020-10-15 2020-10-14 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -642 996.948 -0,06 33,09 -21.244 32.989.607
2020-10-15 2020-10-13 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -10.370 5.726.304 -0,18 33,39 -346.271 191.210.453
2020-10-15 2020-10-13 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -1.369 997.590 -0,14 33,39 -45.713 33.311.126
2020-10-13 2020-10-12 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -353 5.736.674 -0,01 33,11 -11.687 189.926.934
2020-10-13 2020-10-12 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -47 998.959 0,00 33,11 -1.556 33.073.035
2020-10-13 2020-10-09 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -3.357 5.737.027 -0,06 33,67 -113.018 193.145.619
2020-10-13 2020-10-09 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -443 999.006 -0,04 33,67 -14.914 33.633.035
2020-10-13 2020-10-08 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -8.502 5.740.384 -0,15 33,68 -286.352 193.339.577
2020-10-13 2020-10-08 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -7.774 5.748.886 -0,14 33,25 -258.461 191.132.638
2020-10-13 2020-10-08 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -1.122 999.449 -0,11 33,68 -37.790 33.662.042
2020-10-13 2020-10-08 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -1.027 1.000.571 -0,10 33,25 -34.145 33.265.884
2020-10-08 2020-10-07 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.449 10.178 16,60
2020-10-08 2020-10-07 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -4.131 0 -100,00
2020-10-08 2020-10-07 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 3.098 4.131 299,90
2020-10-08 2020-10-07 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -57.424 486.597 -10,56
2020-10-08 2020-10-07 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.033 1.033
2020-10-08 2020-10-07 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -192.576 1.631.864 -10,56
2020-10-08 2020-10-07 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 22 8.729 0,25
2020-10-08 2020-10-07 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -588 0 -100,00
2020-10-08 2020-10-07 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 588 588
2020-10-08 2020-10-07 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -593 0 -100,00
2020-10-08 2020-10-07 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 593 593
2020-10-08 2020-10-07 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -39.608 1.001.598 -3,80
2020-10-08 2020-10-07 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -24.590 5.756.660 -0,43 33,56 -825.154 193.173.361
2020-10-08 2020-10-07 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -3.246 1.041.206 -0,31 33,56 -108.924 34.939.229
2020-10-08 2020-10-06 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -15.980 5.781.250 -0,28 33,26 -531.477 192.278.016
2020-10-08 2020-10-06 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -2.110 1.044.452 -0,20 33,26 -70.176 34.737.325
2020-09-24 2020-09-22 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 14.780 22.171 199,97
2020-09-24 2020-09-22 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other X -1.948 10.355 -15,83
2020-09-24 2020-09-22 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -84.544 0 -100,00
2020-09-24 2020-09-22 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 84.544 84.544
2020-09-24 2020-09-22 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other X -328.324 1.746.493 -15,82
2020-09-22 2020-09-18 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -3.035 518.190 -0,58 86,87 -263.636 45.012.678
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.449 8.707 19,96
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -4.131 0 -100,00
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 3.098 4.131 299,90
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -57.424 544.021 -9,55
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.033 1.033
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -192.576 1.824.440 -9,55
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 42 7.258 0,58
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -1.177 0 -100,00
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.177 1.177
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -1.187 0 -100,00
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.187 1.187
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -79.216 1.046.562 -7,04
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 2.289 7.216 46,46
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -6.901 0 -100,00
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 6.901 6.901
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -8.000 0 -100,00
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 8.000 8.000
2020-09-21 2020-09-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -400.000 5.797.230 -6,45
2020-09-18 2020-09-16 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -8.965 521.225 -1,69 86,98 -779.777 45.336.255
2020-09-16 2020-09-14 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.155 530.190 -0,22 84,89 -98.045 45.006.610
2020-09-11 2020-09-10 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -8.684 531.345 -1,61 85,90 -745.930 45.640.995
2020-09-11 2020-09-10 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -14.161 540.029 -2,56 85,03 -1.204.066 45.916.992
2020-09-11 2020-09-09 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 7.391 7.391
2020-09-11 2020-09-09 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -42.272 0 -100,00
2020-09-11 2020-09-09 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 42.272 42.272
2020-09-11 2020-09-09 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -974 12.303 -7,34
2020-09-11 2020-09-09 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -164.162 2.074.817 -7,33
2020-09-03 2020-09-01 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -15.000 15.000 -50,00
2020-09-03 2020-09-01 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -15.000 15.000 -50,00
2020-09-03 2020-09-01 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -30.000 30.000 -50,00
2020-09-03 2020-09-01 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -200 0 -100,00 93,74 -18.748
2020-09-03 2020-09-01 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -19.135 200 -98,97 92,98 -1.779.256 18.597
2020-09-03 2020-09-01 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -36.365 19.335 -65,29 92,40 -3.360.162 1.786.573
2020-09-03 2020-09-01 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -4.300 55.700 -7,17 91,27 -392.477 5.083.951
2020-09-03 2020-09-01 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 15.000 60.000 33,33 59,31 889.650 3.558.600
2020-09-03 2020-09-01 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 15.000 45.000 50,00 13,62 204.300 612.900
2020-09-03 2020-09-01 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 30.000 30.000 14,00 420.000 420.000
2020-08-20 2020-08-18 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.718 4.927 53,54
2020-08-20 2020-08-18 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -5.176 0 -100,00
2020-08-20 2020-08-18 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 5.176 5.176
2020-08-20 2020-08-18 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -6.000 0 -100,00
2020-08-20 2020-08-18 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 6.000 6.000
2020-08-20 2020-08-18 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other -300.000 6.197.230 -4,62
2020-08-14 2020-08-12 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.718 3.209 115,22
2020-08-14 2020-08-12 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -5.176 0 -100,00
2020-08-14 2020-08-12 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 5.176 5.176
2020-08-14 2020-08-12 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -6.000 0 -100,00
2020-08-14 2020-08-12 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 6.000 6.000
2020-08-14 2020-08-12 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -300.000 6.497.230 -4,41
2020-08-12 2020-08-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -6.692 6.797.230 -0,10 33,08 -221.380 224.861.205
2020-08-12 2020-08-11 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -883 1.125.778 -0,08 33,08 -29.211 37.242.200
2020-08-12 2020-08-10 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -5.492 6.803.922 -0,08 33,04 -181.446 224.789.336
2020-08-12 2020-08-10 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
S - Sale X -725 1.126.661 -0,06 33,04 -23.953 37.222.851
2020-07-29 2020-07-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X 42 1.491 2,90
2020-07-29 2020-07-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -1.177 0 -100,00
2020-07-29 2020-07-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.177 1.177
2020-07-29 2020-07-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -1.187 0 -100,00
2020-07-29 2020-07-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.187 1.187
2020-07-29 2020-07-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -79.217 1.127.386 -6,57
2020-07-29 2020-07-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X 1.449 1.449
2020-07-29 2020-07-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -4.131 0 -100,00
2020-07-29 2020-07-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 3.098 4.131 299,90
2020-07-29 2020-07-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -57.424 601.445 -8,72
2020-07-29 2020-07-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other 1.033 1.033
2020-07-29 2020-07-27 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
J - Other X -192.576 2.017.016 -8,72
2020-07-08 2020-07-06 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.311 554.190 -0,95 83,00 -440.810 45.997.437
2020-07-08 2020-07-06 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -14.689 559.501 -2,56 82,16 -1.206.920 45.971.344
2020-06-24 2020-06-23 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -10.000 574.190 -1,71 75,35 -753.453 43.262.518
2020-06-24 2020-06-22 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -10.000 584.190 -1,68 72,51 -725.069 42.357.806
2020-06-15 2020-06-11 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 15.000 15.000
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -1.055.960 0 -100,00
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -314.873 0 -100,00
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -1.370.833 0 -100,00
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -2.444.382 0 -100,00
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1.517.940 0 -100,00
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -452.630 0 -100,00
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1.970.572 0 -100,00
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -3.851.526 0 -100,00
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -1.148.474 0 -100,00
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -15.000.000 0 -100,00
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
P - Purchase 396.081 1.206.603 48,87 19,00 7.525.539 22.925.457
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
P - Purchase 396.082 6.809.414 6,18 19,00 7.525.558 129.378.866
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
P - Purchase 23.560 658.869 3,71 19,00 447.640 12.518.511
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
P - Purchase 79.013 2.209.592 3,71 19,00 1.501.247 41.982.248
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
C - Conversion 350.141 2.130.579 19,67
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
C - Conversion 104.407 635.309 19,67
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
C - Conversion 454.548 6.413.332 7,63
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
C - Conversion 810.522 810.522
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
C - Conversion 503.327 1.780.438 39,41
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
C - Conversion 150.085 530.902 39,41
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
C - Conversion 653.412 5.958.784 12,32
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
C - Conversion 1.277.111 1.277.111
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
C - Conversion 380.817 380.817
2020-02-05 2020-02-03 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
C - Conversion 4.973.787 5.305.372 1.500,00
2020-01-29 3 BDTX Black Diamond Therapeutics, Inc.
Common Stock
663.170
2020-01-29 3 BDTX Black Diamond Therapeutics, Inc.
Common Stock
663.170
2020-01-29 3 BDTX Black Diamond Therapeutics, Inc.
Common Stock
663.170
2019-11-21 2019-11-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -28.255 596.741 -4,52 67,41 -1.904.783 40.228.698
2019-11-21 2019-11-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -13.745 0 -100,00 67,41 -926.605
2019-11-01 2019-10-30 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -21.000 13.745 -60,44 51,89 -1.089.675 713.218
2019-06-13 2019-06-11 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 15.000 15.000
2018-06-15 2018-06-15 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 30.000 30.000
2018-05-17 2018-05-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -1.000 640.014 -0,16 58,73 -58.730 37.588.022
2018-05-17 2018-05-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -43.000 641.014 -6,29 57,97 -2.492.710 37.159.582
2018-05-09 2018-05-08 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.900 34.745 -7,70 51,38 -149.002 1.785.198
2018-05-09 2018-05-08 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -6.341 37.645 -14,42 50,16 -318.065 1.888.273
2018-05-09 2018-05-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -582 90.730 -0,64 51,26 -29.833 4.650.820
2018-05-09 2018-05-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -249 38.772 -0,64 51,26 -12.764 1.987.453
2018-05-09 2018-05-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -225 34.977 -0,64 51,26 -11.534 1.792.921
2018-05-09 2018-05-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -7.645 1.192.139 -0,64 51,26 -391.883 61.109.045
2018-05-09 2018-05-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -7.424 91.312 -7,52 50,31 -373.501 4.593.907
2018-05-09 2018-05-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -3.172 39.021 -7,52 50,31 -159.583 1.963.147
2018-05-09 2018-05-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.862 35.202 -7,52 50,31 -143.987 1.771.013
2018-05-09 2018-05-07 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -97.550 1.199.784 -7,52 50,31 -4.907.740 60.361.133
2018-05-02 2018-04-30 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.044 98.736 -2,03 50,29 -102.793 4.965.433
2018-05-02 2018-04-30 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -874 42.193 -2,03 50,26 -43.927 2.120.620
2018-05-02 2018-04-30 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -788 38.064 -2,03 50,29 -39.629 1.914.239
2018-05-02 2018-04-30 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -26.860 1.297.334 -2,03 50,29 -1.350.789 65.242.927
2018-04-30 2018-04-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -779 100.780 -0,77 50,03 -38.973 5.042.023
2018-04-30 2018-04-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -333 43.067 -0,77 50,01 -16.653 2.153.781
2018-04-30 2018-04-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -300 38.852 -0,77 50,08 -15.024 1.945.708
2018-04-30 2018-04-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -10.236 1.324.194 -0,77 50,02 -512.005 66.236.184
2018-04-30 2018-04-26 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -14.086 101.559 -12,18 50,11 -705.849 5.089.121
2018-04-30 2018-04-26 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -6.019 43.400 -12,18 50,12 -301.672 2.175.208
2018-04-30 2018-04-26 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.430 39.152 -12,18 50,12 -272.152 1.962.298
2018-04-30 2018-04-26 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -185.075 1.334.430 -12,18 50,11 -9.274.108 66.868.287
2018-04-26 2018-04-24 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -1.528 115.645 -1,30 51,00 -77.928 5.897.895
2018-04-26 2018-04-24 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -653 49.419 -1,30 51,00 -33.303 2.520.369
2018-04-26 2018-04-24 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -589 44.582 -1,30 50,60 -29.803 2.255.849
2018-04-26 2018-04-24 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -20.071 1.519.505 -1,30 51,00 -1.023.621 77.494.755
2018-04-24 2018-04-23 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -6.821 117.173 -5,50 50,66 -345.552 5.935.984
2018-04-24 2018-04-23 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.915 50.072 -5,50 51,00 -148.665 2.553.672
2018-04-24 2018-04-23 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.630 45.171 -5,50 51,00 -134.130 2.303.721
2018-04-24 2018-04-23 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -89.628 1.539.576 -5,50 50,66 -4.540.554 77.994.920
2018-04-24 2018-04-20 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 16.262 43.986 58,66
2018-04-24 2018-04-20 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -92.918 0 -100,00
2018-04-24 2018-04-20 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other 92.918 92.918
2018-04-24 2018-04-20 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -2.947 13.277 -18,16
2018-04-24 2018-04-20 4 CRSP CRISPR Therapeutics AG
Common Shares
J - Other -497.053 2.238.979 -18,17
2017-12-27 2017-12-22 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -26.016 27.724 -48,41 20,30 -528.237 562.916
2017-11-28 2017-11-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -200 53.740 -0,37 20,24 -4.048 1.087.698
2017-11-28 2017-11-24 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.507 53.940 -2,72 20,21 -30.450 1.089.912
2017-09-07 2017-09-05 4 CRSP CRISPR Therapeutics AG
Common Stock
J - Other 55.447 55.447
2017-09-07 2017-09-05 4 CRSP CRISPR Therapeutics AG
Common Stock
J - Other -1.240 0 -100,00
2017-09-07 2017-09-05 4 CRSP CRISPR Therapeutics AG
Common Stock
J - Other 1.240 1.240
2017-09-07 2017-09-05 4 CRSP CRISPR Therapeutics AG
Common Stock
J - Other -17.283 0 -100,00
2017-09-07 2017-09-05 4 CRSP CRISPR Therapeutics AG
Common Stock
J - Other 17.283 17.283
2017-09-07 2017-09-05 4 CRSP CRISPR Therapeutics AG
Common Stock
J - Other -292.529 0 -100,00
2017-09-07 2017-09-05 4 CRSP CRISPR Therapeutics AG
Common Stock
J - Other 292.529 292.529
2017-09-07 2017-09-05 4 CRSP CRISPR Therapeutics AG
Common Stock
J - Other -26.491 52.987 -33,33
2017-09-07 2017-09-05 4 CRSP CRISPR Therapeutics AG
Common Stock
J - Other -61.993 123.994 -33,33
2017-09-07 2017-09-05 4 CRSP CRISPR Therapeutics AG
Common Stock
J - Other -23.899 47.801 -33,33
2017-09-07 2017-09-05 4 CRSP CRISPR Therapeutics AG
Common Stock
J - Other -814.599 1.629.204 -33,33
2017-09-07 2017-09-05 4 CRSP CRISPR Therapeutics AG
Common Stock
J - Other -8.110 16.224 -33,33
2017-09-07 2017-09-05 4 CRSP CRISPR Therapeutics AG
Common Stock
J - Other -1.368.013 2.736.032 -33,33
2017-06-02 2017-05-31 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 30.000 30.000
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Series B Preferred Shares
C - Conversion -5.774 0 -100,00
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Series B Preferred Shares
C - Conversion -13.180 0 -100,00
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Series B Preferred Shares
C - Conversion -5.210 0 -100,00
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Series B Preferred Shares
C - Conversion -173.167 0 -100,00
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Series B Preferred Shares
C - Conversion -1.454 0 -100,00
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Series B Preferred Shares
C - Conversion -231.077 0 -100,00
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Series A-3 Preferred Shares
C - Conversion -73.704 0 -100,00
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Series A-3 Preferred Shares
C - Conversion -168.224 0 -100,00
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Series A-3 Preferred Shares
C - Conversion -66.490 0 -100,00
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Series A-3 Preferred Shares
C - Conversion -2.210.417 0 -100,00
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Series A-2 Preferred Shares
C - Conversion -19.524 0 -100,00
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Series A-2 Preferred Shares
C - Conversion -3.100.477 0 -100,00
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Series A-1 Preferred Shares
C - Conversion -2.754 0 -100,00
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Series A-1 Preferred Shares
C - Conversion -437.247 0 -100,00
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
C - Conversion 5.774 79.478 7,83
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
C - Conversion 73.704 73.704
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
P - Purchase 4.583 185.987 2,53 14,00 64.162 2.603.818
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
C - Conversion 13.180 181.404 7,83
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
C - Conversion 168.224 168.224
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
C - Conversion 5.210 71.700 7,84
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
C - Conversion 66.490 66.490
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
P - Purchase 60.219 2.443.803 2,53 14,00 843.066 34.213.242
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
C - Conversion 173.167 2.383.584 7,83
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
C - Conversion 2.210.417 2.210.417
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
P - Purchase 602 24.334 2,54 14,00 8.428 340.676
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
C - Conversion 1.454 23.732 6,53
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
C - Conversion 19.524 22.278 708,93
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
C - Conversion 2.754 2.754
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
P - Purchase 95.596 4.104.045 2,38 14,00 1.338.344 57.456.630
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
C - Conversion 231.077 4.008.449 6,12
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
C - Conversion 3.100.477 3.777.372 458,04
2016-12-23 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
C - Conversion 437.247 676.895 182,45
2016-12-23 2016-10-18 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 30.000 60.000 100,00
2016-12-23 3/A CRSP CRISPR Therapeutics AG
Common Shares
684.014
2016-12-23 3/A CRSP CRISPR Therapeutics AG
Common Shares
239.648
2016-10-20 2016-10-18 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 30.000 30.000
2016-10-18 3 CRSP CRISPR Therapeutics AG
Common Shares
923.662
2016-10-18 3 CRSP CRISPR Therapeutics AG
Common Shares
821.303
2016-10-18 3 CRSP CRISPR Therapeutics AG
Common Shares
923.662
2016-10-18 3 CRSP CRISPR Therapeutics AG
Common Shares
821.303
2016-06-10 2016-06-08 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 4.194 20.739 25,35 14,00 58.716 290.346
2016-06-10 2016-06-08 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 710.091 3.511.670 25,35 14,00 9.941.274 49.163.380
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
P - Purchase 596.477 1.931.094 44,69 5,00 2.982.385 9.655.470
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -182.914 1.334.617 -12,05 0,01 -1.829 13.346
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -73.615 1.517.531 -4,63 0,01 -736 15.175
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
P - Purchase 3.523 11.408 44,68 5,00 17.615 57.040
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -1.080 7.885 -12,05 0,01 -11 79
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -435 8.965 -4,63 0,01 -4 90
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2015-05-11 2014-11-07 4/A INGN Inogen Inc
Common Stock
S - Sale -3.150 55.345 -5,39 23,95 -75.442 1.325.507
2015-05-11 2014-11-06 4/A INGN Inogen Inc
Common Stock
S - Sale -4.238 58.495 -6,76 24,56 -104.092 1.436.737
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 1.469 3.782 63,51
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 5.199 13.640 61,59
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 5.596 5.596
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 2.798 3.041 1.151,44
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 243 243
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other -42.216 0 -100,00
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 42.216 42.216
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other -389.136 2.917.544 -11,77
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other -3.476 26.061 -11,77
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 4.682 4.682
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.539 52.985 49,48
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 8.916 13.196 208,32
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.834 17.834
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other -136.039 0 -100,00
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 486 13.682 3,68
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 136.039 136.039
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other -778.272 1.263.716 -38,11
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other -6.952 7.812 -47,09
2015-01-06 2015-01-05 4 INGN Inogen Inc
Common Stock
S - Sale -7.946 0 -100,00 30,98 -246.159
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 2.084 9.785 27,06
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.636 35.446 27,46
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 305 4.280 7,67
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 3.975 3.975
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.946 7.946
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -60.344 0 -100,00
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 1.126 60.344 1,90
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 59.218 59.218
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -486.420 2.041.988 -19,24
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -4.345 14.764 -22,74
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -9.235 31.334 -22,76
2014-12-29 2014-12-23 4 INGN Inogen Inc
Common Stock
S - Sale -9.785 0 -100,00 29,74 -291.009
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 2.084 9.785 27,06
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.636 35.446 27,46
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 305 4.280 7,67
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 3.975 3.975
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.946 7.946
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -60.344 0 -100,00
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 1.126 60.344 1,90
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 59.218 59.218
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -486.420 2.041.988 -19,24
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -4.345 14.764 -22,74
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -9.235 31.334 -22,76
2014-12-02 3/A EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.370.964
2014-12-02 3/A EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
82.949
2014-12-02 3/A EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
39.062
2014-11-19 2014-11-19 4 INGN Inogen Inc
Common Stock
S - Sale -3.500 0 -100,00 24,22 -84.757
2014-11-19 2014-11-18 4 INGN Inogen Inc
Common Stock
S - Sale -7.953 0 -100,00 24,79 -197.158
2014-11-19 2014-11-18 4 INGN Inogen Inc
Common Stock
S - Sale -3.895 3.500 -52,67 24,92 -97.054 87.212
2014-11-19 2014-11-17 4 INGN Inogen Inc
Common Stock
S - Sale -7.534 7.395 -50,47 24,86 -187.322 183.866
2014-11-19 2014-11-17 4 INGN Inogen Inc
Common Stock
S - Sale -5.343 40.569 -11,64 24,89 -132.962 1.009.568
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-14 2014-11-14 4 INGN Inogen Inc
Common Stock
S - Sale -3.928 45.912 -7,88 25,06 -98.446 1.150.679
2014-11-14 2014-11-13 4 INGN Inogen Inc
Common Stock
S - Sale -5.505 49.840 -9,95 25,18 -138.640 1.255.190
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 3.919 7.701 103,62
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.170 27.810 103,89
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.929 14.929
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 486 7.953 6,51
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 7.467 7.467
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -113.112 0 -100,00
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 113.112 113.112
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -6.952 19.109 -26,68
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -778.272 2.528.408 -23,54
2014-11-12 2014-11-10 4 INGN Inogen Inc
Common Stock
S - Sale -5.596 0 -100,00 24,48 -136.979
2014-11-12 2014-11-10 4 INGN Inogen Inc
Common Stock
S - Sale -3.041 0 -100,00 24,57 -74.712
2014-11-07 2014-11-07 4 INGN Inogen Inc
Common Stock
S - Sale -3.150 55.345 -5,39 23,95 -75.442 1.325.507
2014-11-07 2014-11-06 4 INGN Inogen Inc
Common Stock
S - Sale -4.238 58.495 -6,76 24,56 -104.092 1.436.737
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 1.469 3.782 63,51
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.199 13.640 61,59
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.596 5.596
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 2.798 3.041 1.151,44
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 243 243
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other -3.476 26.061 -11,77
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 2.313 2.313
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 8.441 8.441
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 4.404 4.647 1.812,35
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other -66.857 0 -100,00
2014-09-12 2014-09-10 4 FLXN Flexion Therapeutics Inc
Stock Option (right to buy)
X - Other -2.250 6.750 -25,00
2014-09-12 2014-09-10 4 FLXN Flexion Therapeutics Inc
Common Stock
X - Other 2.250 2.250 17,61 39.622 39.622
2014-03-04 2014-03-03 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
A - Award 9.000 9.000
2014-02-20 2014-02-18 4 FLXN Flexion Therapeutics Inc
Series B Preferred Stock
C - Conversion -3.153.677 0 -100,00
2014-02-20 2014-02-18 4 FLXN Flexion Therapeutics Inc
Series A Preferred Stock
C - Conversion -19.556.148 0 -100,00
2014-02-20 2014-02-18 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 307.692 3.206.807 10,61 13,00 3.999.996 41.688.491
2014-02-20 2014-02-18 4 FLXN Flexion Therapeutics Inc
Common Stock
C - Conversion 387.906 2.899.115 15,45
2014-02-20 2014-02-18 4 FLXN Flexion Therapeutics Inc
Common Stock
C - Conversion 2.405.429 2.511.209 2.273,99
2014-02-11 3 FLXN Flexion Therapeutics Inc
Common Stock
211.560
2014-02-11 3 FLXN Flexion Therapeutics Inc
Common Stock
211.560
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)